This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.